Diarylpyrimidine, nonnucleoside reverse transcriptase inhibitor (NNRTI). Prepn: B. De Corte et al., WO 0027825; eidem, US 7037917 (2000, 2006, both to Janssen); and anti-HIV activity: D. W. Ludovici et al., Bioorg. Med. Chem. Lett. 11, 2235 (2001) DOI PubMed. Crystal structure of complex with HIV reverse transcriptase: K. Das et al., J. Med. Chem. 47, 2550 (2004) DOI PubMed. Antiretroviral spectrum and resistance potential: J. Vingerhoets et al., J. Virol. 79, 12773 (2005) DOI PubMed. Clinical pharmacokinetics and antiretroviral activity in drug-resistant patients: M. Boffito et al., AIDS 21, 1449 (2007) DOI PubMed. Clinical trials in treatment experienced patients: J. V. Madruga et al., Lancet 370, 29 (2007) DOI PubMed; A. Lazzarin et al., ibid. 39 DOI PubMed.
Antiretroviral.
Reverse Transcriptase Inhibitor; Antiretroviral; Reverse Transcriptase Inhibitors; Nonnucleosides